Vioxx
Vioxx is a painkiller, but it's been in the mainstream news because Vioxx has been linked to heart problems.
Evidence of cardiovascular risks associated with taking Vioxx, the popular, nonsteroidal anti-inflammatory drug (rofecoxib), could have been identified nearly four years before its manufacturer, Merck & Co. Inc., voluntarily pulled the drug from the market, according to new data.
From ivanhoe.com
()
- Vioxx trial data shows early cardiovascular risk (sciencedaily.com)
Evidence that the painkiller Vioxx might increase the risk of heart attacks and strokes emerged nearly four years before the drug was voluntarily withdrawn from the market, research has shown.
Vioxx, the brand name for rofecoxib, was designed to fight the pain of arthritis. It was launched in May 1999 by Merck & Co Inc. But in September 2004, Merck voluntarily pulled Vioxx following a large trial that was halted early after finding evidence...
More perspectives...
From sott.net
()
We have long been writing about the links between Merck’s blockbuster nonsteroidal, anti-inflammatory medication Vioxx (rofecoxib) and negative cardiac events. Now, according to Science Daily, a study has found that evidence of cardiovascular risks linked to Vioxx might have been realized almost four years before Merck & Co. Inc., pulled the drug from the market. Vioxx [...]
From personalinjurylawnews.com
()
- Vioxx risks could have been identified years earlier (latimes.com)
Boston (DbTechNo) - It appears that heart risks associated with Vioxx were known about up to 3 years before Merck pulled their drug from the market.
The painkiller was pulled from the market back in 2004, after it became apparent that the drug had severe heart attack risk in patients who received it.
This news comes from [...]
From dbtechno.com
()
- Merck wins summary judgment in Texas lawsuit (marketwatch.com)
- Trials showed Vioxx risk 'years before withdrawal' (france24.com)
- Merck Wins Summary Judgment in Texas Attorney General's Lawsuit Involving... (businesswire.com)
Before the headlines hit about the dangers of using Vioxx (rofecoxib), researchers were already aware, say news reports.
Vioxx, a non-steroidal anti-inflammatory (NSAID), was made by Merck & Co. Inc., and introduced to the American market in 1999. The company then voluntarily pulled the drug from the market in September 2004, after there were multiple reports of increased risk of heart attack and stroke associated with long-term, high-dose use...
More perspectives...
From aheartylife.com
()
NEW YORK, Nov. 24 (UPI) -- Merck & Co. is disputing it knew Vioxx significantly increased the risk of heart attacks at least three years before it was pulled off the market.
More perspectives...
From upi.com
()
WHITEHOUSE STATION, N.J. - Merck & Co. said today that a district court judge in Texas dismissed all claims in a state Medicaid lawsuit over the painkiller Vioxx.
From philly.com
()
- Merck claims win in Texas lawsuit over Vioxx (dailyreportonline.com)
- Texas Court dismisses all claims against Merck in VIOXX-related lawsuit (News... (personalinjurylawnews.com)
- Merck Wins Summary Judgment In Texas Lawsuit (story.indiagazette.com)
